Estimating the Clinical and Economic Impact of Maintaining use of 13-valent Pneumococcal Conjugate Vaccine (PCV13) in Mexico

BACKGROUND: PCV13 replaced 7-valent pneumococcal conjugate vaccine in the routine infant immunization schedule in Mexico since 2011. The use of PCV13 has reduced pneumococcal disease incidence for vaccine serotypes, particularly 19A, which emerged following PCV7 use. The 10-valent vaccine (PCV10) co...

Descripción completa

Detalles Bibliográficos
Autores principales: Wasserman, Matt, Wilson, Michele, McDade, Cheryl, Grajales, Ana Gabriela, Palacios, Maria Gabriela, Baez- Revueltas, Fabiola Berenice, Farkouh, Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631395/
http://dx.doi.org/10.1093/ofid/ofx163.1183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631395/
http://dx.doi.org/10.1093/ofid/ofx163.1183

Ejemplares similares